GlassScriptPhysician profile
Laura Kuperman
NPI 1467465617
$2,328.06
in general payments reported to CMS, 2019-2025
16 companies · $186 in 2025
The $186 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $166 · 2021: $337 · 2022: $697 · 2023: $292 · 2024: $406 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $884.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $884.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $330.45 | 2020-2024 | |
| Astellas Pharma US INC | $288.41 | 2023-2025 | Veozah |
| Amgen INC. | $250.00 | 2019-2022 | |
| Lilly USA, LLC | $250.00 | 2023-2024 | Mounjaro |
| Intuity Medical INC | $183.15 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Amryt Pharma Holdings LTD | $150.01 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $129.00 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $125.00 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2022 | |
| Phathom Pharmaceuticals, INC. | $123.48 | 2024 | Voquezna |
| Sumitomo Pharma America, INC. | $109.95 | 2023-2025 | Myfembree |
| Janssen Pharmaceuticals, INC | $101.69 | 2019 | |
| Cequr Corporation | $77.17 | 2022 | |
| Agile Therapeutics, INC. | $56.78 | 2023-2024 | Twirla |
| Therapeuticsmd, INC. | $16.19 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dysis Medical, INC. | $11.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Kuperman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.